2026年11月3日星期二
M
환우통감
글로벌 속보
Working collaboratively to fight scams in Asia Pacific— Google 官方博客Vienna entrepreneur takes leaders on lux train to China to foster ties— 日经 Nikkei AsiaBangladesh garment factories become second schools for women— 日经 Nikkei AsiaThailand to raise tax on imported EVs to 35% as Chinese brands gain ground— 日经 Nikkei AsiaWhy PC makers are turning back to China— 日经 Nikkei AsiaAustralia gold miner Northern Star lifts output amid investor pressure— 日经 Nikkei AsiaMalaysia transport minister still plans to quit, says megaprojects safe— 日经 Nikkei AsiaApple's new CEO delivers first earnings as sales hit record— 日经 Nikkei AsiaWorking collaboratively to fight scams in Asia Pacific— Google 官方博客Vienna entrepreneur takes leaders on lux train to China to foster ties— 日经 Nikkei AsiaBangladesh garment factories become second schools for women— 日经 Nikkei AsiaThailand to raise tax on imported EVs to 35% as Chinese brands gain ground— 日经 Nikkei AsiaWhy PC makers are turning back to China— 日经 Nikkei AsiaAustralia gold miner Northern Star lifts output amid investor pressure— 日经 Nikkei AsiaMalaysia transport minister still plans to quit, says megaprojects safe— 日经 Nikkei AsiaApple's new CEO delivers first earnings as sales hit record— 日经 Nikkei Asia

MCP-1 licenses mesenchymal stem cells for T-cell-supportive function

출처 Nature 生命科学1일 전
내용 요약

본 사이트는 제목과 요약 색인만 제공하며, 전체 내용과 저작권은 모두 원 발행처에 있습니다. 원문 링크를 클릭하여 읽어 주세요.

원문 보기
소속 채널
과학
소속 지역
글로벌 시각
원문 언어
English
항목 번호
science-25fe9377

Comments 0 comments

No comments yet. Be the first.

MCP-1 licenses mesenchymal stem cells for T-cell-supportive function · 환우통감